Aurobindo Pharma Limited has appointed B Govindarajan as chief executive officer for its APIs and CRAMS (contract research and manufacturing services) business effective October 7, 2010. An engineer by training from Annamalai University and having almost two decades of experience, Govindarajan served as the MD & CEO of Shasun Pharmaceuticals prior to joining Aurobindo, it informed the BSE.